Literature DB >> 15300079

Incidence of cataract extraction after diabetic vitrectomy.

William E Smiddy1, William Feuer.   

Abstract

PURPOSE: To determine the frequency of visually significant cataracts after vitrectomy for complications of diabetic retinopathy.
METHODS: We studied 40 patients and 56 concurrent control patients in a retrospective, consecutive, comparative case series in an institutional setting. Entry criteria included phakic patients with a clear lens or mild lens opacity undergoing anatomically successful diabetic vitrectomy, without lens removal at the time of vitrectomy, without intraocular gas or silicone oil use, and with at least 1 year of postoperative follow-up examination information. Two comparative phakic control groups with the diagnosis of macular hole or epiretinal membrane were selected, also with follow-up examination information of at least 1 year postoperatively. The occurrence of cataract extraction was the principal outcome measure. Its validity as a measure of cataract formation was evaluated by ascertainment of improved visual acuity after cataract extraction. A secondary endpoint analysis included eyes that needed cataract extraction at the final follow-up examination.
RESULTS: For the primary analyses (clear lens preoperatively), there were 26 patients in the study group, 38 in the macular hole control group, and 18 in the epiretinal membrane control group. The cumulative cataract extraction rates at 2 years were 15%, 66%, and 53% respectively. By using multivariate survival analysis, the patient age was an important factor, with a younger age associated with a lower rate of progression to nuclear sclerosis. After controlling for age, the difference in these three groups was still statistically significant. In the four patients with diabetes undergoing cataract surgery, the visual acuity improved at least two lines in only one of the eyes and did not change in three eyes. After expanding the outcome measures to include study patients with mild lens opacities at baseline or those judged to be in need of cataract surgery at the final follow-up examination, there was still a strongly statistically significant difference between the three groups.
CONCLUSION: The rate of cataract extraction after vitrectomy in patients with diabetes is lower than in patients without diabetes undergoing vitrectomy and suggests a lower rate of cataract formation. This inference should be considered when attributing subnormal vision in a patient who has had a diabetic vitrectomy to a cataract. This is especially significant because the risk ratio in patients with diabetes in general and in patients with a previous vitrectomy is likely less favorable compared with the general population.

Entities:  

Mesh:

Year:  2004        PMID: 15300079     DOI: 10.1097/00006982-200408000-00011

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  18 in total

1.  Prediction of postoperative visual outcome after pars plana vitrectomy based on preoperative multifocal electroretinography in eyes with diabetic macular edema.

Authors:  Yong Min Kim; Soo Young Lee; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-06       Impact factor: 3.117

2.  Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice.

Authors:  B Gupta; R Wong; S Sivaprasad; T H Williamson
Journal:  Eye (Lond)       Date:  2012-01-13       Impact factor: 3.775

3.  Combined pars plana vitrectomy (PPV) and phacoemulsification (phaco) versus PPV and deferred phaco for phakic patients with full-thickness macular hole (FTMH) and no significant cataract at baseline: 1-year outcomes of a randomized trial combined PPV/phaco vs PPV/deferred phaco for MH.

Authors:  Karlos Ítalo S Viana; Camila T Gordilho; Felipe P P Almeida; Marcelo M Esperandio; David R Lucena; Denny M Garcia; Ingrid U Scott; André M V Messias; Rodrigo Jorge
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-06       Impact factor: 3.117

4.  Ischemic diabetic retinopathy may protect against nuclear sclerotic cataract.

Authors:  Nancy M Holekamp; Fang Bai; Ying-Bo Shui; Arghavan Almony; David C Beebe
Journal:  Am J Ophthalmol       Date:  2010-08-04       Impact factor: 5.258

Review 5.  Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.

Authors:  Jaafar El Annan; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014

Review 6.  Oxidative damage and the prevention of age-related cataracts.

Authors:  David C Beebe; Nancy M Holekamp; Ying-Bo Shui
Journal:  Ophthalmic Res       Date:  2010-09-09       Impact factor: 2.892

7.  Cost comparison of scleral buckle versus vitrectomy for rhegmatogenous retinal detachment repair.

Authors:  Michael I Seider; Ayman Naseri; Jay M Stewart
Journal:  Am J Ophthalmol       Date:  2013-07-20       Impact factor: 5.258

Review 8.  Surgery for Diabetic Eye Complications.

Authors:  María H Berrocal; Luis A Acaba; Alexandra Acaba
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

9.  Effect of lens status on intraocular pressure in siliconized eyes.

Authors:  Ahmed A Mohalhal; Malak I El Shazly; Dalia A Ghalwash
Journal:  Clin Ophthalmol       Date:  2012-02-21

10.  Long-term follow-up after vitrectomy to treat idiopathic full-thickness macular holes: visual acuity and macular complications.

Authors:  Hirokazu Sakaguchi; Masahito Ohji; Yusuke Oshima; Yasushi Ikuno; Fumi Gomi; Naoyuki Maeda; Motohiro Kamei; Shunji Kusaka; Kohji Nishida
Journal:  Clin Ophthalmol       Date:  2012-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.